35.77
-0.61(-1.68%)
Currency In USD
| Previous Close | 36.38 |
| Open | 36.48 |
| Day High | 36.98 |
| Day Low | 35.57 |
| 52-Week High | 62.79 |
| 52-Week Low | 35.14 |
| Volume | 348,348 |
| Average Volume | 947,637 |
| Market Cap | 2.04B |
| PE | -2.39 |
| EPS | -14.98 |
| Moving Average 50 Days | 43.5 |
| Moving Average 200 Days | 44.37 |
| Change | -0.61 |
If you invested $1000 in Enovis Corporation (ENOV) 10 years ago, it would be worth $428.59 as of March 13, 2025 at a share price of $35.77. Whereas If you bought $1000 worth of Enovis Corporation (ENOV) shares 5 years ago, it would be worth $884.36 as of March 13, 2025 at a share price of $35.77.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Enovis Announces Planned CEO Succession Process
GlobeNewswire Inc.
Feb 26, 2025 11:00 AM GMT
Wilmington, DE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), a leader in medical technology innovation, announced today that Matt Trerotola has informed the Board of Directors (the “Board”) of his
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
GlobeNewswire Inc.
Jan 29, 2025 12:00 PM GMT
Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and
Enovis™ Announces Leadership Change to International Surgical Business
GlobeNewswire Inc.
Jan 17, 2025 11:00 AM GMT
Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin Reinmann as President of Enovis International Su